lookindex

Cagrilintide

Also known as CagriSema (with semaglutide), AM833

The trial results are strong, but they are for a combination with semaglutide that is still waiting on regulators. Anything sold online as cagrilintide is not the trial drug.

Information only. Not medical advice. Talk to a doctor before you start, stop or change anything.

What people claim

  • Stronger than Ozempic
  • Keeps the weight off without losing muscle
  • Research-grade vials are the same as the trial drug

What the evidence shows

  • In REDEFINE 1, 3,417 adults without diabetes lost 20.4% of body weight over 68 weeks on the combination with semaglutide, against 3.0% on placebo.[1]
  • In the same trial, the combination led to more weight loss than either drug on its own.[1]
  • In a body-scan subgroup, about a third of the weight lost was lean tissue rather than fat.[1]
  • In REDEFINE 2, adults with type 2 diabetes lost 13.7% against 3.4% on placebo.[2]

Known risks

  • Stomach side effects were reported by 72.5% of people on the combination, against 34.4% on placebo.[2]
  • Unapproved GLP-1 type products sold online have been linked to dosing errors and fakes.[3]
  • TGA testing found unapproved peptides often do not contain what their labels claim.[4]

Reported side effects

Moderated user reports are not open yet, so nothing is shown here. They will be labelled as unverified personal accounts.

Legal status

A summary, not legal advice. Rules change, and sport bans are separate.

United States

Unapproved

Not FDA approved.

United Kingdom

Unlicensed

No licensed medicine contains it. Products sold outside trials are unlicensed.

Australia

Not approved

TGA says importing, advertising or supplying unapproved peptides is unlawful.[5]

European Union

Not authorised

No authorised medicine. National rules on possession and import differ.

Sources

  1. 1.Coadministered cagrilintide and semaglutide in adults with overweight or obesity (REDEFINE 1)New England Journal of Medicine, 2025
  2. 2.Cagrilintide and semaglutide in adults with overweight or obesity and type 2 diabetes (REDEFINE 2)New England Journal of Medicine, 2025
  3. 3.FDA's concerns with unapproved GLP-1 drugs used for weight lossUS FDA
  4. 4.TGA testing finds unapproved peptides do not contain what their labels claimTGA Australia, Nov 2026
  5. 5.Importing, compounding and supplying unapproved peptide productsTGA Australia

Profile last checked 7 Nov 2026.